跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OJJAARA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OJJAARA
Authorized
STANDARD
OJJAARA
GlaxoSmithKline Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cd3d5cd8cc7c767b
Company
GlaxoSmithKline Inc
Type
Standard
Approval Details
Approval Id
cd3d5cd8cc7c767b
Drug Approval Canada Name
OJJAARA
Product Name
OJJAARA
Status
Marketed
Status Date
2025-01-21
Original Market Date
2025-01-21
Din
02552973
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EJ04 MOMELOTINIB
Atc Name
l 01 ej 04
Aig Number
0166324002
Company Name
GlaxoSmithKline Inc
Company Address
800, 100 Milverton Drive, Mississauga, Ontario, Canada, L5R 4H1
Company Detail Path
/organization/glaxosmithkline-inc
Company Information
Pharmaceutical Company Name
GlaxoSmithKline Inc
Country Name
Canada
Province Name
Ontario
City Name
mississauga,ontario,country_ca
Address
800-100 Milverton Dr
Active Ingredients
MOMELOTINIB (MOMELOTINIB DIHYDROCHLORIDE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cd3d5cd8cc7c767b
Type
Standard
Back to Health Canada Approvals